Fierce Healthcare February 5, 2018
Boosted by the FDA’s new approach to mobile apps, “digiceuticals” could soon be prescribed like traditional drugs.
Despite some caution from venture capitalists, digital apps could take on a more formal role in treating disease.
In some cases, that could mean an app that is prescribed a physician, either as a standalone treatment or in conjunction with traditional drugs.
Digital therapeutics or “digiceuticals” still haven’t emerged as a widely-used treatment option for doctors. But that could change with more interest from drug companies and as more mobile solutions gain approval from the Food and Drug Administration (FDA).
As many as 150 firms around the world are developing digital therapeutics, according to the Economist. But funding for those ventures hasn’t...
Today's Sponsors
Today's Sponsor